Low doses of ultraviolet radiation stimulate cell activity in collagen-based scaffolds

Biotechnology Progress

Volumn 24, Issue 4, 2008, Pages 884-889

  Rajan, Navneeta ^a   Lagueux, Jean ^a   Couet, Frédéric ^a   Pennock, William ^a   Mantovani, Diego ^a   Sionkowska, Alina ^b  

^a UNIVERSITÉ LAVAL   (Canada)

^b NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Collagen; Fibroblasts; MTT; Scaffolds; Ultraviolet radiation; Vascular tissue engineering

Indexed keywords

BIOLOGICAL MATERIALS; BIOMECHANICS; BLOOD VESSEL PROSTHESES; BLOOD VESSELS; CELLS; COLLOIDS; CROSSLINKING; CYTOLOGY; EXTRACTION; GELATION; MECHANICAL PROPERTIES; OPTICAL DESIGN; SCAFFOLDS; SULFUR COMPOUNDS; SUPRAMOLECULAR CHEMISTRY; TECHNOLOGY; TISSUE ENGINEERING; ULTRAVIOLET RADIATION;

ALL OVER THE WORLD; CARDIO-VASCULAR DISEASES; CELL ACTIVITIES; CHEMICAL-; COLLAGEN GELS; COLLAGEN STRUCTURES; COLLAGEN-BASED SCAFFOLDS; EXTRAORDINARY PROPERTIES; FIBROBLASTS; GLYCATION; MTT; NATURAL TISSUES; PHYSICAL TREATMENTS; UNDESIRABLE EFFECTS; UV IRRADIATIONS; UV RADIATION; VASCULAR TISSUE ENGINEERING;

COLLAGEN;

BIOMATERIAL; COLLAGEN; TISSUE SCAFFOLD;

ANIMAL; CELL STRAIN 3T3; CELL SURVIVAL; CHEMISTRY; CONFERENCE PAPER; EXTRACELLULAR MATRIX; FIBROBLAST; MOUSE; PHYSIOLOGY; RADIATION DOSE; RADIATION EXPOSURE; TISSUE ENGINEERING; ULTRAVIOLET RADIATION;

ANIMALS; BIOCOMPATIBLE MATERIALS; CELL SURVIVAL; COLLAGEN; EXTRACELLULAR MATRIX; FIBROBLASTS; MICE; NIH 3T3 CELLS; RADIATION DOSAGE; TISSUE ENGINEERING; TISSUE SCAFFOLDS; ULTRAVIOLET RAYS;

EID: 51849100227     PISSN: 87567938     EISSN: None     Source Type: Journal    
DOI: 10.1002/btpr.3     Document Type: Conference Paper

References (24)

1. Mackay J, Mensah G. The Atlas of Heart Disease and Stroke. Geneva: World Health Organization; 2004: pp. 112.
2. Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld J, Manolio T, Zheng ZJ, Flegal K, O'Donnell C, Kittner S, Lloyd-Jones DK, Goff DC, Hong Y. Heart disease and stroke statistics - 2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2006;113:e85-151.
3. Petersen S, Peto V, Rayner M, et al. European Cardiovascular Disease Statistics 2005. London: British Heart Foundation; 2005: pp. 100
4. Langer R, Vacanti JP. Tissue engineering. Science. 1993;260:920-926.
5. Kakisis JD, Liapis CD, Breuer C, Sumpio BE. Artificial blood vessel: the Holy Grail of peripheral vascular surgery. J Vasc Surg. 2005;41:349-354.
6. Bou-Gharios G, Ponticos M, Rajkumar V, Abraham D. Extra-cellular matrix in vascular networks. Cell Prolif. 2004;37:207-220.
7. Jacob MP, Badier-Commander C, Fontaine V, et al. Extracellular matrix remodeling in the vascular wall. Pathol Biol (Paris). 2001;49:326-332.
8. Weinberg C, Bell E. A blood vessel model constructed from collagen and cultured vascular cells. Science. 1986;231:397-400.
9. Habermehl J, Skopinska J, Boccafoschi F, et al. Preparation of ready-to-use, stockable and reconstituted collagen. Macromol Biosci. 2005;5:821-828.
10. Boccafoschi F, Habermehl J, Vesentini S, Mantovani D. Biological performances of collagen-based scaffolds for vascular tissue engineering. Biomaterials. 2005;26:7410-7417.
11. Boccafoschi F, Rajan N, Habermehl J, Mantovani D. Preparation and characterization of a scaffold for vascular tissue engineering by direct-assembling of collagen and cells in a cylindrical geometry. Macromol Biosci. 2007;7:719-726.
12. Rajan N, Habermehl J, Cote MF, et al. Preparation of ready-to-use, storable and reconstituted type I collagen from rat tail tendon for tissue engineering applications. Nat Protoc. 2006;1:2753-2758.
13. Koob T. Collagen fixation. In: G. Wnek, G. Bowlin, eds. Encyclopedia of Biomaterials and Biomedical Engineering. New-York: Informa Healthcare; 2004:335-347.
14. Ohan M, Weadock K, Dunn M. Synergistic effects of glucose and ultraviolet irradiation on the physical properties of collagen. J Biomed Mater Res. 2002;60:384-391.
15. Couet F, Mantovani D. Experimental validation of a new approach for the development of mechano-compatible composite scaffolds for vascular tissue engineering. J Mater Sci Mater Med. 2008;19:2551-2554.
16. Rasband W. ImageJ. Bethesda, MD: National Institutes of Health; 1997-2004.
17. Cote M-F, Laroche G, Gagnon E, et al. Denatured collagen as support for a FGF-2 delivery system: physicochemical characterizations and in vitro release kinetics and bioactivity. Biomaterials. 2004;25:3761-3772.
18. Lee CH, Singla A, Lee Y. Biomedical applications of collagen. Int J Pharmaceut. 2001;221:1-22.
19. Charulatha V, Rajaram A. Influence of different crosslinking treatments on the physical properties of collagen membranes. Biomaterials. 2003;24:759-767.
20. Weadock KS, Miller EJ, Bellincampi LD, et al. Physical crosslinking of collagen fibers: comparison of ultraviolet irradiation and dehydrothermal treatment. J Biomed Mater Res. 1995;29:1373-1379.
21. Bailey AJ. Molecular mechanisms of ageing in connective tissues. Mech Ageing Dev. 2001;122:735-755.
22. Girton TS, Oegema TR, Tranquillo RT. Exploiting glycation to stiffen and strengthen tissue equivalents for tissue engineering. J Biomed Mater Res. 1999;46:87-92.
23. Bilodeau K, Couet F, Boccafoschi F, Mantovani D. Design of a perfusion bioreactor specific to the regeneration of vascular tissues under mechanical stresses. Artif Org. 2005;29:906-912.
24. 2. Conversion of proline residue to 2-pyrrolidone. J Biol Chem. 1992;267:23646-23651.